Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human blood

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 1625-1636

  Chan, Wing Keung ^a   Rujkijyanont, Piya ^a   Neale, Geoffrey ^a   Yang, Jie ^a   Bari, Rafijul ^a   Gupta, Neha Das ^a   Holladay, Martha ^a   Rooney, Barbara ^a   Leung, Wing ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; DNAM 1 PROTEIN; INTERLEUKIN 13; INTERLEUKIN 17; KIR PROTEIN; KIR2DL2 PROTEIN; KIR2DL3 PROTEIN; LYMPHOCYTE ANTIGEN; NKG2C PROTEIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CELL; CD56+ T LYMPHOCYTE; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOTOXICITY; EFFECTOR CELL; ENERGY METABOLISM; FEMALE; GENETIC ASSOCIATION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; KIR+ CD56+ T LYMPHOCYTE; KIR+ T LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MALE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TELOMERE; TH17 CELL; VIRUS REACTIVATION;

ANTIGENS, CD56; ANTIGENS, CD57; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ASYMPTOMATIC DISEASES; BONE MARROW TRANSPLANTATION; CELL LINE, TUMOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; METABOLOME; MULTIPLEX POLYMERASE CHAIN REACTION; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, KIR; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3; T-LYMPHOCYTE SUBSETS; TELOMERE; TH17 CELLS; TISSUE DONORS; TRANSCRIPTOME; VIRUS ACTIVATION;

EID: 84881450402     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300111     Document Type: Article

References (75)

1. Vivier, E., D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
2. Rothenberg, E. V. 2010. Lineage determination in the immune system. Immunol. Rev. 238: 5-11.
3. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
4. Bari, R., T. Bell, W. H. Leung, Q. P. Vong, W. K. Chan, N. Das Gupta, M. Holladay, B. Rooney, and W. Leung. 2009. Significant functional heterogeneity among KIR2DL1 alleles and a pivotal role of arginine 245. Blood 114: 5182-5190.
5. Ciofani, M., and J. C. Zúñiga-Pflücker. 2010. Determining γδ versus αß T cell development. Nat. Rev. Immunol. 10: 657-663.
6. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
7. Phillips, J. H., J. E. Gumperz, P. Parham, and L. L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268: 403-405.
8. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 93: 12433-12438.
9. Young, N. T., M. Uhrberg, J. H. Phillips, L. L. Lanier, and P. Parham. 2001. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 166: 3933-3941.
10. Ferrini, S., A. Cambiaggi, R. Meazza, S. Sforzini, S. Marciano, M. C. Mingari, and L. Moretta. 1994. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 24: 2294-2298.
11. Battistini, L., G. Borsellino, G. Sawicki, F. Poccia, M. Salvetti, G. Ristori, and C. F. Brosnan. 1997. Phenotypic and cytokine analysis of human peripheral blood γδT cells expressing NK cell receptors. J. Immunol. 159: 3723-3730.
12. null T cells. J. Immunol. 168: 3839-3846.
13. + T cells. J. Immunol. 173: 7223-7229.
14. +) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. J. Immunol. 181: 4219-4228.
15. + T cells specific for cytomegalovirus. J. Immunol. 182: 4175-4182.
16. Vivier, E., and N. Anfossi. 2004. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4: 190-198.
17. Mingari, M. C., G. Pietra, and L. Moretta. 2005. Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors. Curr. Opin. Immunol. 17: 312-319.
18. + cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 100: 10896-10901.
19. + T cells is controlled by T-cell receptor engagement. Nature 403: 325-328.
20. + T cells. Nat. Immunol. 2: 430-435.
21. Marti, F., C. W. Xu, A. Selvakumar, R. Brent, B. Dupont, and P. D. King. 1998. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 95: 11810-11815.
22. Chwae, Y. J., M. J. Chang, S. M. Park, H. Yoon, H. J. Park, S. J. Kim, and J. Kim. 2002. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J. Immunol. 169: 3726-3735.
23. Gati, A., N. Guerra, C. Gaudin, S. Da Rocha, B. Escudier, Y. Lécluse, A. Bettaieb, S. Chouaib, and A. Caignard. 2003. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. Cancer Res. 63: 7475-7482.
24. + T cells. J. Immunol. 182: 92-101.
25. + T cells. J. Immunol. 180: 4550-4560.
26. van Bergen, J., and F. Koning. 2010. The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR. Immunology 131: 301-309.
27. Björkström, N. K., V. Béziat, F. Cichocki, L. L. Liu, J. Levine, S. Larsson, R. A. Koup, S. K. Anderson, H. G. Ljunggren, and K. J. Malmberg. 2012. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood 120: 3455-3465.
28. Uhrberg, M., N. M. Valiante, N. T. Young, L. L. Lanier, J. H. Phillips, and P. Parham. 2001. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical αβTCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J. Immunol. 166: 3923-3932.
29. Vely, F., M. Peyrat, C. Couedel, J. Morcet, F. Halary, F. Davodeau, F. Romagne, E. Scotet, X. Saulquin, E. Houssaint, et al. 2001. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166: 2487-2494.
30. Stewart, C. A., J. Van Bergen, and J. Trowsdale. 2003. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 170: 6073-6081.
31. Chan, H. W., Z. B. Kurago, C. A. Stewart, M. J. Wilson, M. P. Martin, B. E. Mace, M. Carrington, J. Trowsdale, and C. T. Lutz. 2003. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 197: 245-255.
32. Santourlidis, S., H. I. Trompeter, S. Weinhold, B. Eisermann, K. L. Meyer, P. Wernet, and M. Uhrberg. 2002. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169: 4253-4261.
33. Presnell, S. R., L. Zhang, C. A. Ramilo, H. W. Chan, and C. T. Lutz. 2006. Functional redundancy of transcription factor-binding sites in the killer cell Iglike receptor (KIR) gene promoter. Int. Immunol. 18: 1221-1232.
34. Trompeter, H. I., N. Gómez-Lozano, S. Santourlidis, B. Eisermann, P. Wernet, C. Vilches, and M. Uhrberg. 2005. Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J. Immunol. 174: 4135-4143.
35. Xu, J., A. N. Vallejo, Y. Jiang, C. M. Weyand, and J. J. Goronzy. 2005. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J. Biol. Chem. 280: 24277-24285.
36. Li, G., M. Yu, C. M. Weyand, and J. J. Goronzy. 2009. Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood 114: 3422-3430.
37. D'Andrea, A., C. Chang, J. H. Phillips, and L. L. Lanier. 1996. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J. Exp. Med. 184: 789-794.
38. Guerra, N., F. Michel, A. Gati, C. Gaudin, Z. Mishal, B. Escudier, O. Acuto, S. Chouaib, and A. Caignard. 2002. Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 100: 2874-2881.
39. De Maria, A., A. Ferraris, M. Guastella, S. Pilia, C. Cantoni, L. Polero, M. C. Mingari, D. Bassetti, A. S. Fauci, and L. Moretta. 1997. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. Proc. Natl. Acad. Sci. USA 94: 10285-10288.
40. Mandelboim, O., D. M. Davis, H. T. Reyburn, M. Valés-Gómez, E. G. Sheu, L. Pazmany, and J. L. Strominger. 1996. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 274: 2097-2100.
41. Mandelboim, O., S. Kent, D. M. Davis, S. B. Wilson, T. Okazaki, R. Jackson, D. Hafler, and J. L. Strominger. 1998. Natural killer activating receptors trigger interferon γ-secretion from T cells and natural killer cells. Proc. Natl. Acad. Sci. USA 95: 3798-3803.
42. Snyder, M. R., T. Nakajima, P. J. Leibson, C. M. Weyand, and J. J. Goronzy. 2004. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J. Immunol. 173: 3725-3731.
43. + cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell. Immunol. 136: 486-495.
44. Lemster, B. H., J. J. Michel, D. T. Montag, J. J. Paat, S. A. Studenski, A. B. Newman, and A. N. Vallejo. 2008. Induction of CD56 and TCRindependent activation of T cells with aging. J. Immunol. 180: 1979-1990.
45. + T cells closely correlates with CD56 surface expression. J. Immunol. 164: 1148-1152.
46. Metelitsa, L. S., O. V. Naidenko, A. Kant, H. W. Wu, M. J. Loza, B. Perussia, M. Kronenberg, and R. C. Seeger. 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167: 3114-3122.
47. Leung, W., D. Campana, J. Yang, D. Pei, E. Coustan-Smith, K. Gan, J. E. Rubnitz, J. T. Sandlund, R. C. Ribeiro, A. Srinivasan, et al. 2011. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 118: 223-230.
48. Leung, W., G. Neale, F. Behm, R. Iyengar, D. Finkelstein, M. B. Kastan, and C. H. Pui. 2010. Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia. Cancer Epidemiol 34: 303-308.
49. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102: 15545-15550.
50. Bruhns, P., B. Iannascoli, P. England, D. A. Mancardi, N. Fernandez, S. Jorieux, and M. Daëron. 2009. Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses. Blood 113: 3716-3725.
51. Pende, D., S. Marcenaro, M. Falco, S. Martini, M. E. Bernardo, D. Montagna, E. Romeo, C. Cognet, M. Martinetti, R. Maccario, et al. 2009. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113: 3119-3129.
52. + natural killer-like cells. Nat. Immunol. 10: 66-74.
53. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
54. Ferreira, L. M. 2013. γδT cells: innately adaptive immune cells? Int. Rev. Immunol. 10.3109/08830185.2013.783831.
55. van der Windt, G. J., and E. L. Pearce. 2012. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249: 27-42.
56. Finlay, D., and D. A. Cantrell. 2011. Metabolism, migration and memory in cytotoxic T cells. Nat. Rev. Immunol. 11: 109-117.
57. Wang, R., and D. R. Green. 2012. Metabolic checkpoints in activated T cells. Nat. Immunol. 13: 907-915.
58. Annunziato, F., L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani. 2009. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat. Rev. Rheumatol. 5: 325-331.
59. Michel, M. L., D. Mendes-da-Cruz, A. C. Keller, M. Lochner, E. Schneider, M. Dy, G. Eberl, and M. C. Leite-de-Moraes. 2008. Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105: 19845-19850.
60. Mingari, M. C., M. Ponte, C. Cantoni, C. Vitale, F. Schiavetti, S. Bertone, R. Bellomo, A. T. Cappai, and R. Biassoni. 1997. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int. Immunol. 9: 485-491.
61. + T cells in vitro and following congenital infection with Trypanosoma cruzi. Immunology 129: 418-426.
62. + T cells in the elderly. Blood 114: 3360-3361.
63. hi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
64. + natural killer cells with potent function. Blood 119: 2665-2674.
65. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
66. Petitdemange, C., P. Becquart, N. Wauquier, V. Béziat, P. Debré, E. M. Leroy, and V. Vieillard. 2011. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 7: e1002268.
67. Béziat, V., O. Dalgard, T. Asselah, P. Halfon, P. Bedossa, A. Boudifa, B. Hervier, I. Theodorou, M. Martinot, P. Debré, et al. 2012. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
68. Parham, P., P. J. Norman, L. Abi-Rached, and L. A. Guethlein. 2012. Humanspecific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367: 800-811.
69. Leung, W., R. Iyengar, B. Triplett, V. Turner, F. G. Behm, M. S. Holladay, J. Houston, and R. Handgretinger. 2005. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J. Immunol. 174: 6540-6545.
70. Henel, G., K. Singh, D. Cui, S. Pryshchep, W. W. Lee, C. M. Weyand, and J. J. Goronzy. 2006. Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood 107: 4449-4457.
71. + innate lymphoid cells. Curr. Opin. Immunol. 23: 361-367.
72. Newcomb, D. C., M. G. Boswell, M. M. Huckabee, K. Goleniewska, D. E. Dulek, S. Reiss, N. W. Lukacs, J. K. Kolls, and R. S. Peebles, Jr. 2012. IL- 13 regulates Th17 secretion of IL-17A in an IL-10-dependent manner. J. Immunol. 188: 1027-1035.
73. + Th17 cells and IL-13 signaling attenuates Th17 cytokine production. J. Immunol. 182: 5317-5321.
74. Zhu, S., and Y. Qian. 2012. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin. Sci. 122: 487-511.
75. Serody, J. S., and G. R. Hill. 2012. The IL-17 differentiation pathway and its role in transplant outcome. Biol. Blood Marrow Transplant. 18: S56-S61.